Fig. 4From: Systemic administration of c-Kit+ cells diminished pulmonary and vascular inflammation in rat model of chronic asthmaProtein levels of VCAM-1 evaluated using IHC. Data showed that asthma induction promoted VCAM-1 levels compared to the Control group. Administration of C-kit− cells and C-kit+ cells can reduce protein levels of VCAM-1. These effects are more prominent in asthmatic group received C-kit positive cellsBack to article page